Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Aug
5
2019
Employment Law This Week®: Cannabis User Protections, WHD Opinion Letters, New Salary History Bans, NYS Anti-Harassment Training Deadline [VIDEO] Epstein Becker & Green, P.C.
Sep
25
2019
FDA Guidance Clarifies HDE Program Review Epstein Becker & Green, P.C.
Jun
1
2023
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study Epstein Becker & Green, P.C.
Jun
13
2023
An “Overbroad” Noncompete – the NLRB Has Found Its First Target Epstein Becker & Green, P.C.
Apr
3
2020
Legal Liability of Healthcare Providers for Care Provided During COVID-19 Pandemic Epstein Becker & Green, P.C.
May
6
2024
Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies? Epstein Becker & Green, P.C.
Feb
4
2022
2022 Mental Health Parity Report to Congress Highlights Increased Enforcement Efforts Epstein Becker & Green, P.C.
Aug
22
2019
Are Efforts to Speed Up Antitrust Merger Reviews Working? Epstein Becker & Green, P.C.
Aug
4
2015
The Future of Research Using Electronic Medical Records Data: Precision Medicine Initiative Privacy and Trust Guiding Principles Provide Another Piece of the Puzzle Epstein Becker & Green, P.C.
Aug
1
2023
Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Sep
1
2023
CMS Names Its First Ten Negotiated Part D Drugs: Inflation Reduction Act Updates Epstein Becker & Green, P.C.
Mar
24
2020
FDA Confirms That At-Home Collection Kits Are Not Authorized for Use with COVID-19 Tests Epstein Becker & Green, P.C.
Mar
31
2020
HHS Issues Blanket Waivers for Certain Financial Relationships Subject to the Stark Law Epstein Becker & Green, P.C.
Dec
19
2023
Health Care Workers Engaged in Treatment, Payment, or Operations Excluded by BIPA Epstein Becker & Green, P.C.
Jun
29
2020
Current Good Manufacturing Practices in the Time of COVID-19: FDA Announces New Expectations on Risk Assessment and Risk Management Epstein Becker & Green, P.C.
Jul
27
2020
In Response to COVID-19, FDA Extends Enforcement Discretion for HCT/Ps Requiring Pre-Market Review Epstein Becker & Green, P.C.
Mar
26
2024
Last Call for Comments on the Bipartisan Discussion Draft of the SUSTAIN Act: Shaping 340B for the Future Epstein Becker & Green, P.C.
Sep
25
2020
Deadline Looms for Responding to DEA’s Proposed Aggregate Production Quotas for 2021 Epstein Becker & Green, P.C.
May
10
2017
Commissioner Scott Gottlieb’s Priorities as Newly Approved FDA Commissioner Epstein Becker & Green, P.C.
Apr
7
2021
#WorkforceWednesday: Action Pending from Biden’s OFCCP and OSHA Epstein Becker & Green, P.C.
Jun
8
2021
New Class Action Litigation Claims That Fish Oil Is The Modern-Day Snake Oil Epstein Becker & Green, P.C.
Jan
4
2022
Unpacking Averages: Likelihood of FDA Medical Device Inspections Epstein Becker & Green, P.C.
Jan
19
2022
Video: SCOTUS Decides on Vaccine Rules, Companies Can Still Require Vaccination, Restrictive Covenants in CO – Employment Law This Week Epstein Becker & Green, P.C.
Nov
15
2018
OIG Publishes Report: FDA’s “Deficient” Cybersecurity Policies and Procedures Need Improvement Epstein Becker & Green, P.C.
May
23
2019
The Role of Patient Preference in Medical Device Evaluation Epstein Becker & Green, P.C.
Aug
1
2023
FDA’s LDT Proposed Rule Heads to the White House Epstein Becker & Green, P.C.
Sep
5
2023
State Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law Epstein Becker & Green, P.C.
Nov
20
2023
Sharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don’ts Under FDA’s New Draft Guidance Epstein Becker & Green, P.C.
Mar
7
2024
Making Moves – FDA’s LDT Proposed Rule Sent to OMB for Review Epstein Becker & Green, P.C.
Jun
3
2021
Federal and State Cannabis Rules Are Moving in Different Directions – Diagnosing Health Care [PODCAST] Epstein Becker & Green, P.C.
Jun
25
2018
Cheers to 80 Years: Celebrating the Anniversary of the Federal Food, Drug, and Cosmetic Act Epstein Becker & Green, P.C.
Dec
16
2021
CMS Issues Guidance on COVID-19 Testing in the Workplace Epstein Becker & Green, P.C.
Jan
22
2019
Not Business as Usual: The Government Shutdown’s Impact at FDA Epstein Becker & Green, P.C.
Jun
22
2022
The Pendulum Swings Both Ways: State Responses to Protect Reproductive Health Data, Post-Roe Epstein Becker & Green, P.C.
Jul
1
2019
Nevada Becomes First State to Prohibit Rejection of Applicants Testing Positive for Marijuana Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins